Pharmacokinetics of Intraperitoneal Piperacillin/Tazobactam in Patients on Peritoneal Dialysis with and without Pseudomonas Peritonitis

Author:

Zaidenstein Ronit1,Weissgarten Joshua2,Dishi Victor2,Koren Maya1,Soback Stefan3,Gips Marina3,Averbuch Zhan2,Simantov Roman1,Assulin Etty2,Golik Ahuva1

Affiliation:

1. Departments of Internal Medicine “A” Assaf Harofeh Medical Center, Zerifin, with Sackler Faculty of Medicine, Tel Aviv University

2. Nephrology, Assaf Harofeh Medical Center, Zerifin, with Sackler Faculty of Medicine, Tel Aviv University

3. Kimron Veterinary Institute, Beit Dagan, Israel

Abstract

ObjectiveThe objective of this study was to assess the pharmacokinetics of intraperitoneal (IP) administration of the antibiotic combination piperacillin/tazobactam (PIP/TAZ) to patients on chronic ambulatory peritoneal dialysis (CAPD) with and without pseudomonas peritonitis.DesignOpen-labeled study.SettingThe study was carried out in the CAPD unit of Assaf Harofeh Medical Center, Zerifin, Israel.Patients and MethodsSix patients participated in the study, 4 had pseudomonas peritonitis, all were given an IP loading dose of 4 g/0.5 g PIP/TAZ. Twenty-four hours after the initial dose, a maintenance dose of 0.5 g/0.0625 g PIP/TAZ was administered with each dialysate exchange for a period of 1 week. The patients without peritonitis received only the loading dose. High performance liquid chromatography was used to determine the concentrations of PIP/TAZ in plasma obtained at 0, 30, 60, 90, 120, 360, 480, 600, 720, and 1440 minutes after administration. Samples of the dialysate fluid for determination of PIP/TAZ concentration were collected at 6, 10, 14, 24, and 72, 120, and 168 hours.ResultsAfter the loading dose, the highest plasma PIP concentration (Cmax) was 51.6 ± 21.25 μg/mL and appeared at 1.5 ± 0.45 hours (tmax). During the maintenance period plasma PIP concentration was 5.2 ± 4.75 μg/mL. Tazobactam was detected in the plasma of 1 patient only. The concentration of TAZ in the dialysate fluid during the maintenance period was 2.3 ± 0.5 μg/mL.ConclusionsPiperacillin administered IP at 4 g reached plasma concentrations comparable to intravenous administration and considered therapeutic (above the MIC90for Pseudomonas aeruginosa) in CAPD patients with or without peritonitis. The maintenance dose, however, should be augmented. Tazobactam could not be detected in the plasma of most patients and the therapeutic implications of IP administration of TAZ cannot be directly correlated to intravenous administration.

Publisher

SAGE Publications

Subject

Nephrology,General Medicine

Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Pharmacokinetics of intravenous piperacillin/tazobactam among patients with peritoneal dialysis-associated peritonitis;Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis;2024-04-26

2. Pharmacokinetic and Pharmacodynamic Basis of Optimal Antimicrobial Therapy;Principles and Practice of Pediatric Infectious Diseases;2023

3. ISPD peritonitis guideline recommendations: 2022 update on prevention and treatment;Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis;2022-03

4. Anti-Infective Agents;Demystifying Drug Dosing in Renal Dysfunction;2019-05-31

5. Pharmacokinetic-Pharmacodynamic Basis of Optimal Antibiotic Therapy;Principles and Practice of Pediatric Infectious Diseases;2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3